[Strategies to optimize adherence to antiretroviral treatment. Interventions in the therapeutic regimen]
- PMID: 14756993
- DOI: 10.1016/s0213-005x(04)73044-x
[Strategies to optimize adherence to antiretroviral treatment. Interventions in the therapeutic regimen]
Abstract
Within the first few years after the introduction of highly active antiretroviral therapy two facts became evident: the treatment was highly effective and proper compliance was essential to achieve the therapeutic objectives. Recently, the regimens containing these drugs have changed. Complex dosing with a large number of tablets taken three times daily together with dietary restrictions has given way to simpler treatments.The main advances include new formulations and new drugs that allow once-daily dosing, the use of ritonavir to enhance the bioavailability of the protease inhibitors and the coformulation of active ingredients in a single capsule. This review analyzes the impact of these interventions on the therapeutic regimen and it discusses the factors that facilitate and those that hinder optimal adherence to highly active antiviral treatment. Adherence is a complex, multidimensional problem. Simplification of the treatment is an important aspect, but it should be accompanied by other strategies focussed on the patient and the medical team in order to achieve effective long-term antiretroviral therapy in all patients.
Similar articles
-
[Recommendations from GESIDA/SEFH/PNS to improve adherence to antiviral treatment (2004)].Enferm Infecc Microbiol Clin. 2005 Apr;23(4):221-31. doi: 10.1157/13073149. Enferm Infecc Microbiol Clin. 2005. PMID: 15826548 Spanish.
-
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.JAMA. 2006 Aug 16;296(7):806-14. doi: 10.1001/jama.296.7.806. JAMA. 2006. PMID: 16905786 Clinical Trial.
-
Impact of once- and twice-daily dosing regimens on adherence and overall safety.AIDS Read. 2004 Jun;14(6):320-2, 324, 329-31, 334-6. AIDS Read. 2004. PMID: 15243968 Review.
-
The importance of treatment adherence in HIV.Am J Manag Care. 2013 Sep;19(12 Suppl):s231-7. Am J Manag Care. 2013. PMID: 24495293 Review.
-
Once-daily dosing of nevirapine in HAART.J Antimicrob Chemother. 2008 Jan;61(1):13-6. doi: 10.1093/jac/dkm432. Epub 2007 Nov 14. J Antimicrob Chemother. 2008. PMID: 18006524
Cited by
-
Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD001442. doi: 10.1002/14651858.CD001442.pub2. Cochrane Database Syst Rev. 2006. PMID: 16855968 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical